A detailed history of Silverarc Capital Management, LLC transactions in Incyte Corp stock. As of the latest transaction made, Silverarc Capital Management, LLC holds 49,000 shares of INCY stock, worth $3.04 Million. This represents 0.81% of its overall portfolio holdings.

Number of Shares
49,000
Holding current value
$3.04 Million
% of portfolio
0.81%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$65.08 - $83.38 $3.19 Million - $4.09 Million
49,000 New
49,000 $3.38 Million
Q2 2023

Aug 14, 2023

BUY
$60.95 - $75.51 $10,483 - $12,987
172 Added 0.51%
34,110 $2.12 Million
Q1 2023

May 15, 2023

BUY
$70.23 - $86.01 $2.38 Million - $2.92 Million
33,938 New
33,938 $2.45 Million

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $13.8B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Silverarc Capital Management, LLC Portfolio

Follow Silverarc Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Silverarc Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Silverarc Capital Management, LLC with notifications on news.